This educational program consists of three presentations on the challenge of choosing in CV risk management.

This course consists of the following:

• The importance of optimal RAASi therapy in heart failure - Prof. Dan Atar, MD - Oslo, Norway
• How potassium binders can enable RAASi therapy in heart failure - Prof. Mikhail Kosiborod, MD - Kansas City, MO, USA
• Practical guidance on use of potassium binders in the management of hyperkalemia in heart failure - Clara Bonanad Lozano, MD, PhD - Valencia, Spain

How to obtain your CME certificate

• Watch the three lectures and answer the pre- and post-test questions
• Fill in the evaluation questions
• Download CME Certificate (if your score >70%)

After watching these three videos, the learner should be able to:

• Describe the incidence and clinical consequences of suboptimal RAASi therapy in HF patients
• List the main results of trials with novel potassium binders
• Recall recommendations from recent clinical practice guidelines on the use of potassium binders to manage hyperkalemia in HF

Expert faculty

• Prof. Dan Atar, MD - Oslo, Norway
• Prof. Mikhail Kosiborod, MD - Kansas City, MO, USA
• Clara Bonanad Lozano, MD, PhD - Valencia, Spain

Target audience

This educational activity is designed for all healthcare professionals with an interest in management of patients with heart failure.

CME accreditation

This online course is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credit.

Through an agreement between EBAC and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

Funding

Funding for this educational program was provided by unrestricted educational grants from AstraZeneca.

Questions

For questions regarding this activity, please contact us at info@pace-cme.org.